Back
Range Nuclear Renaissance ETF Vs. Longboard Pharmaceuticals Industry Stock Comparison
Buy
74
NUKZ
Range Nuclear Renaissance ETF
Last Price:
35.35
Seasonality Move:
--
Buy
57
LBPH
Longboard Pharmaceuticals
Last Price:
33.93
Seasonality Move:
-17.05%
Buy
74
Range Nuclear Renaissance ETF (NUKZ)
is a Buy
Is Range Nuclear Renaissance ETF a Buy, Sell or Hold?
- The current Range Nuclear Renaissance ETF [NUKZ] share price is $35.56. The Score for NUKZ is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- NUKZ is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $33.89. The Score for LBPH is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NUKZ Stock Price Chart
What is Range Nuclear Renaissance ETF's stock price today?
-
The Range Nuclear Renaissance ETF share price today is $35.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKZ is experiencing buying pressure, which is a positive indicator for future bullish movement.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $33.89
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing slight selling pressure.
NUKZ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 72.46 | Buy |
| Chaikin Money Flow: | 33114 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.48 - 33.5) | Buy |
| Bollinger Bands (100): | (31.87 - 33.89) | Buy |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 50.99 | Buy |
| Chaikin Money Flow: | -590951 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.08 - 36.28) | Sell |
| Bollinger Bands (100): | (21.09 - 35.99) | Buy |
NUKZ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.12 | Buy |
| 20-day SMA: | 32.45 | Buy |
| 50-day SMA: | 32.49 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 33.37 | Buy |
| 20-day EMA: | 32.69 | Buy |
| 50-day EMA: | 32.53 | Buy |
| 200-day EMA: | 10.63 | Buy |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.02 | Buy |
| 20-day SMA: | 33.9 | Sell |
| 50-day SMA: | 34.81 | Sell |
| 200-day SMA: | 23.39 | Buy |
| 8-day EMA: | 32.41 | Buy |
| 20-day EMA: | 33.31 | Buy |
| 50-day EMA: | 32.77 | Buy |
| 200-day EMA: | 24.23 | Buy |
Range Nuclear Renaissance ETF Earnings Growth & NUKZ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.21 per share, and a decrease next year of $0.53 per share.
Range Nuclear Renaissance ETF Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||